Diethyl succinate



Compound IDCDAMM01385
Common nameDiethyl succinate
IUPAC namediethyl butanedioate
Molecular formulaC8H14O4

Experimental data

Retention time10.68
Adduct[M+H]+
Actual mz175.098
Theoretical mz175.096
Error6.99
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.4302

Identifiers and class information

Inchi keyDKMROQRQHGEIOW-UHFFFAOYSA-N
SmilesO=C(OCC)CCC(=O)OCC
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)174.196
Computed dipole moment(dipole)0
Total solvent accessible surface area (SASA)475.655
Hydrophobic component of SASA (FOSA)364.531
Hydrophilic component of SASA (FISA)111.124
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)732.123
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4
Free energy of solvation of dipole (dip^2/V)0
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.825902
Predicted polarizability in cubic angstroms (QPpolrz)19.935
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.434
Predicted octanol/gas partition coefficient (QPlogPoct)7.729
Predicted water/gas partition coefficient (QPlogPw)4.457
Predicted octanol/water partition coefficient (QPlogPo/w)1.354
Predicted aqueous solubility (QPlogS)-2.322
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.917
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.349
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)875.206
Predicted brain/blood partition coefficient (QPlogBB)-0.824
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)428.33
Predicted skin permeability, log Kp (QPlogKp)-3.087
PM3 calculated ionization potential (IP(ev))11.131
PM3 calculated electron affinity (EA(eV))-0.587
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-0.539
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)87.534
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)73.892
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P23141CES1Acyl coenzyme A:cholesterol acyltransferaseT76369SEA
O00206TLR4Toll-like receptor 4 (by homology)T81443SwissTargetPrediction
P01375TNFTNF-alphaT20178SEA
Q08752PPIDPeptidyl-prolyl cis-trans isomerase DT52447SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA
Q14191WRNWerner syndrome ATP-dependent helicaseT47583SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T76369DI0335Peroxisomal disease[ICD-11: 5C57]P23141CES1
T76369DI0398Synthesis disorder[ICD-11: 5C52-5C59]P23141CES1
T81443DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]O00206TLR4
T81443DI0346Prostate cancer[ICD-11: 2C82]O00206TLR4
T81443DI0375Sepsis[ICD-11: 1G40-1G41]O00206TLR4
T20178DI0035Arterial occlusive disease[ICD-11: BD40]P01375TNF
T20178DI0274Multiple myeloma[ICD-11: 2A83]P01375TNF
T20178DI0351Psoriasis[ICD-11: EA90]P01375TNF
T20178DI0366Rheumatoid arthritis[ICD-11: FA20]P01375TNF
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T47583DI0251Mature T-cell lymphoma[ICD-11: 2A90]Q14191WRN

Copyright © 2025